Insiders ARS Pharmaceuticals, Inc.

Equities

SPRY

US82835W1080

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-11 pm EDT			5-day change	1st Jan Change
11.11 ^USD	+6.21%		+22.22%	+102.74%

Jul. 11	Ars Pharmaceuticals Insider Sold Shares Worth $961,725, According to a Recent SEC Filing	MT
Jul. 11	Ars Pharmaceuticals Insider Sold Shares Worth $961,725, According to a Recent SEC Filing	MT

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Ars Pharmaceuticals Insider Sold Shares Worth $961,725, According to a Recent SEC Filing	Jul. 11	MT
Ars Pharmaceuticals Insider Sold Shares Worth $961,725, According to a Recent SEC Filing	Jul. 11	MT
Ars Pharmaceuticals Insider Sold Shares Worth $913,917, According to a Recent SEC Filing	Jun. 13	MT
ARS Pharmaceuticals Insider Sold Shares Worth $928,005, According to a Recent SEC Filing	Apr. 18	MT
ARS Pharmaceuticals Insider Sold Shares Worth $928,005, According to a Recent SEC Filing	Apr. 18	MT
Ars Pharmaceuticals Insider Sold Shares Worth $927,735, According to a Recent SEC Filing	Apr. 10	MT
Ars Pharmaceuticals Insider Bought Shares Worth $319,954, According to a Recent SEC Filing	23-10-02	MT
Insider Buy: Ars Pharmaceuticals	23-08-31	MT
Insider Sell: Ars Pharmaceuticals	23-08-07	MT
Insider Sell: ARS Pharmaceuticals	23-06-05	MT
Insider Sell: Ars Pharmaceuticals	23-05-10	MT
ARS Pharmaceuticals, Inc. Appoints Brian T. Dorsey as Chief Operations Officer	22-12-09	CI
Silverback Therapeutics, Inc. Announces Executive Changes	22-09-02	CI
Silverback Therapeutics, Inc. Announces Thilo Schroeder Will Not Stand for Re-Election as Member of the Company Board of Directors	22-03-17	CI
Silverback Therapeutics Announces the Appointment of Dr. Maria Koehler to Its Board of Directors	21-03-15	CI
Silverback Therapeutics, Inc. Appoints Andrew Powell as Director	20-11-10	CI
Silverback Therapeutics, Inc. Announces Executive Promotions	20-09-24	CI
Silverback Therapeutics Appoints Vickie L. Capps to Board of Directors and Audit Committee Chair	20-06-04	CI
Silverback Therapeutics, Inc. Appoints Laura Shawver as President and CEO	20-04-22	CI
Silverback Therapeutics Announces Board Changes	20-03-11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders ARS Pharmaceuticals, Inc.

Equities

SPRY

US82835W1080

Insiders

Filters